Skip to main content

Closed

ENLV: Enlivex Therapeutics Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

2.96×avg

Market Cap

35.18MUSD

P/E Ratio

0.0TTM

Div Yield

-ann

Enlivex Therapeutics Ltd.

ENLVNASDAQ Capital Market·USD·Closed

Enlivex Therapeutics Ltd.

ENLVNASDAQ·USD·Closed

$2.09

+7.18%

$2.09

+$0.14 (7.18%)

52W Range

1thpctl

Volume

2.96×avg

Mkt Cap

35.18MUSD

P/E

0.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings